We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$504B
AUM Growth
+$32.2B
Cap. Flow
+$5.9B
Cap. Flow %
1.17%
Top 10 Hldgs %
18.16%
Holding
6,959
New
774
Increased
2,658
Reduced
2,316
Closed
526

Sector Composition

Rank Sector Weight
1 Technology 16.68%
2 Consumer Discretionary 9%
3 Financials 7.65%
4 Healthcare 7.34%
5 Communication Services 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTEK icon
6051
Fuel Tech
FTEK
$45.2M
$98K ﹤0.01%
70,190
+42,238
+151% +$74.4K
KMDA icon
6052
Kamada
KMDA
$414M
$98K ﹤0.01%
14,942
-34,622
-70% -$206K
QCLS
6053
Q/C Technologies Inc
QCLS
$23.2M
$98K ﹤0.01%
+5
New +$113K
GMDA
6054
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$98K ﹤0.01%
38,482
-40,543
-51% -$134K
ORTX
6055
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$97K ﹤0.01%
7,333
+4,199
+134% +$69.4K
KVSA
6056
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$97K ﹤0.01%
+10,008
New +$98.7K
CDTX
6057
DELISTED
Cidara Therapeutics
CDTX
$96K ﹤0.01%
3,784
-1,711
-31% -$53.3K
ENZ
6058
DELISTED
Enzo Biochem, Inc.
ENZ
$96K ﹤0.01%
30,041
-15,122
-33% -$51.6K
RRAC.WS
6059
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$96K ﹤0.01%
+174,259
New +$109K
MSAIW icon
6060
MultiSensor AI Holdings Warrant
MSAIW
$725K
$95K ﹤0.01%
+201,371
New +$102K
LAB icon
6061
PUT
Standard BioTools
LAB
$307M
$94K ﹤0.01%
+24,100
New +$113K
NRXP icon
6062
NRX Pharmaceuticals
NRXP
$131M
$94K ﹤0.01%
+1,962
New +$142K
EMWP
6063
DELISTED
Eros Media World PLC
EMWP
$94K ﹤0.01%
19,673
+4,050
+26% +$46.3K
MBAC.WS
6064
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$94K ﹤0.01%
80,678
HOOK
6065
DELISTED
HOOKIPA Pharma
HOOK
$93K ﹤0.01%
4,005
+2,609
+187% +$105K
PRTH icon
6066
Priority Technology Holdings
PRTH
$548M
$92K ﹤0.01%
+13,044
New +$80.4K
IMPL
6067
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$92K ﹤0.01%
+10,687
New +$107K
AVAL icon
6068
Grupo Aval
AVAL
$6.29B
$91K ﹤0.01%
17,804
-5
-0% -$28
ICUCW
6069
SeaStar Medical Holding Corp Warrant
ICUCW
$336K
$91K ﹤0.01%
211,381
IZEA icon
6070
IZEA Worldwide
IZEA
$61.6M
$91K ﹤0.01%
+17,004
New +$123K
POLA icon
6071
Polar Power
POLA
$6.48M
$91K ﹤0.01%
3,636
+1,793
+97% +$63K
CEPU
6072
Central Puerto
CEPU
$2.14B
$90K ﹤0.01%
28,666
+13,407
+88% +$46.1K
CTXR icon
6073
Citius Pharmaceuticals
CTXR
$21.4M
$90K ﹤0.01%
2,335
-5,550
-70% -$252K
INZY
6074
DELISTED
Inozyme Pharma
INZY
$90K ﹤0.01%
13,239
-3,326
-20% -$28.7K
MNOV icon
6075
MediciNova
MNOV
$65.5M
$90K ﹤0.01%
33,516
-869
-3% -$2.9K

Similar funds

Goldman Sachs's Q4 2021 Portfolio in Review

As of Q4 2021, Goldman Sachs held 6,959 positions worth $504B, up 6.8% from $471B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs's Q4 2021 filing shows 774 new, 2,658 increased, 2,316 reduced and 526 closed positions. Its largest new stake was Mirion Technologies: 53,265,743 shares worth $558M. The largest sale was Alibaba, an estimated $1.21B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Goldman Sachs's largest Q4 2021 buy was Mirion Technologies: 53,265,743 shares worth $558M.
  • Goldman Sachs added most to Invesco QQQ Trust in Q4 2021, an estimated $1.73B increase.
  • Goldman Sachs's biggest Q4 2021 reduction was Alibaba, cutting an estimated $1.21B.
  • Goldman Sachs fully exited PPD, Inc. Common Stock in Q4 2021, selling an estimated $277M.
  • Goldman Sachs's ten largest holdings make up 18% of its $504B portfolio in Q4 2021.
  • Goldman Sachs opened 774 new positions and closed 526 in Q4 2021.
  • Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $504B.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.